*COMES IN LYOPHILIZED POWDER (FREEZE DRIED) MUST RECONSTITUTE*

TIRZ is a synthetic 39-amino-acid linear peptide that acts as a dual agonist of the glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors. It is extensively researched for its potent effects on metabolic regulation, glycemic control, and body weight management.

Key Details:

• Sequence: Tyr-Aib-Glu-Gly-Thr-Phe-Thr-Ser-Asp-Tyr-Ser-Ile-Aib-Leu-Asp-Lys-Ile-Ala-Gln-Lys-Ala-Phe-Val-Gln-Trp-Leu-Ile-Ala-Gly-Gly-Pro-Ser-Ser-Gly-Ala-Pro-Pro-Pro-Ser-NH₂ (with specific modifications including Aib residues and C-terminal amidation)
• Molecular Formula: C₂₂₇H₃₄₈N₄₈O₆₈
• Molecular Weight: ~4,813.5 Da

Research Applications: TIRZ has been investigated for its ability to:

• Significantly improve insulin secretion and sensitivity
• Promote substantial weight loss through reduced appetite and delayed gastric emptying
• Enhance cardiovascular and metabolic markers in models of metabolic disease and obesity
• Provide superior glycemic control compared to single GLP-1 agonists
• Support long-term metabolic health, fat mass reduction, and preservation of lean mass

It is a leading research compound in the fields of metabolic disease, obesity, and endocrinology.

⚠️ IMPORTANT DISCLAIMERS FOR RESEARCH USE ONLY. NOT FOR HUMAN CONSUMPTION. This product is sold strictly for laboratory research and in vitro testing purposes. It is not intended to diagnose, treat, cure, or prevent any disease. It has not been approved by the FDA (or equivalent regulatory bodies) for human or veterinary use.

Purchasers must be qualified researchers or institutions. Always consult applicable laws and regulations in your jurisdiction. Handling should follow standard laboratory safety protocols for peptides. OrlandoBiogenics.com assumes no liability for misuse of this research chemical.